StonvexLoading…
StonvexStonvexStonvexCore line items from SBH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $948.67M | $1.85B | $943.17M | $3.70B | $2.75B |
Operating Income | Not available | $147.87M | $75.94M | $327.81M | $247.87M |
Net Income | Not available | $88.25M | $45.56M | $195.88M | $145.95M |
EPS (Diluted) | $0.54 | $0.88 | $0.45 | $1.89 | $1.40 |
Total Assets | Not available | $2.85B | $2.85B | $2.87B | $2.74B |
Total Liabilities | Not available | $2.02B | $2.03B | $2.08B | $1.98B |
Cash & Equivalents | Not available | $157.40M | $157.19M | $149.16M | $112.80M |
Free Cash Flow OCF − CapEx | Not available | $101.57M | $57.45M | $172.69M | $94.68M |
Shares Outstanding | Not available | 95.90M | 97.49M | 97.88M | 99.44M |